LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
0250U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0250U.
Elevated code risk
Signal breakdown
7 shown · 7 total in platform
Risk: Elevated
0
Critical
0%
3
High
43%
4
Routine
57%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
LCD L38119: MolDX: Next-Generation Sequencing for Solid Tumors — Noridian
Policy LCD-L38119 · Oncology
New billing guidelines for solid tumors effective 02/05/2026.
LCD L38067: MolDX: Next-Generation Sequencing for Solid Tumors — CGS
Policy LCD-L38067 · Oncology
New NGS guidelines may reshape solid tumor testing billing.
LCD L38121: MolDX: Next-Generation Sequencing for Solid Tumors — Noridian
Policy LCD-L38121 · Oncology
compliance updates with MolDX for oncology testing.
LCD L37810: Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms — NGS
Policy LCD-L37810 · Oncology
NGS LCD covers genomic panels for solid tumor Tx in NY, CT, MA & more.
Audit documentation
Building an audit file that includes 0250U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription